It turns out Inspira will indeed begin trading on July 14th under the ticker LND (Venture).

Michael Dalsin mentioned that they thought about delaying the opening until the fall but he has good business available now that's contingent on the company being public, so on balance it made more sense to start trading next week.

I’ve said it before but I’ll repeat it: I think Inspira is the most attractive of the three Greene/Dalsin companies (and I own all three). It doesn’t have the margins of a Convalo or the diversity of PHM but it certainly has more “blue sky,” meaning a bigger addressable market and more scalability. Making low-risk loans to doctors in an era when their revenues are challenged by changes to insurance policies makes tremendous sense.

(Click here for a New York Times article on the subject.)

I want Inspira to have a strong debut but I also want subscribers to be able to buy it at a good price so maybe a weaker market is a good thing, at least to start. There will be lots of volume, that much is guaranteed, because the 10 cent stock is free trading and sports a 15 cents warrant. It will most likely not have a Covalo-like opening because of the summer and weak sentiment tied to Greece and China. So try to get it for a good price. Let the sellers come to you. The stock has traded in the grey market for 20-30 cents.

The company has raised $30 million already. Here is a capitalization table and some valuation metrics:

Warmest regards,

Fabrice Taylor, CFA | Publisher